센주 대신 다이이찌를 택했다?!개발 끝나자 파트너 전격 교체일본 상업화 승부가 시작됐다#삼천당제약 #SCD411 #아일리아 #센주제약 #다이이찌산쿄 #PFS #권리회수 #DMAH

Investors Health BOMAR ENT. November 5, 2026 · 0 Comment

400만 달러 주고 파트너 전격 교체! 삼천당제약(000250) 일본 SCD411 독점판매 계약 변경과 구조적 대변혁 완벽 해부 …

source

#india Agentic AI AI & Healthcare AI Adopters AI Application AI Capex AI Compute Demand AI Enablers AI Full-Industry Chain AI Hardware AI Infrastructure AI Labor Disruption AI Monetization AI Productivity AI-Enabled Enterprise Software Anti-Internal Competition Balanced Allocation Capex Over Consumption Capital Market Inclusivity China Asset Revaluation Corporate Going Global Corporate Profits Critical Minerals Data Centers Defense Spending Demographic Shifts Diversification Domestic Chip Self-Reliance Earnings Growth Earnings Revisions Emerging Markets Energy Security Energy Storage Energy Transition europe FAFO Financials Foreign Capital Inflow Future of Energy Geographic Diversification Geopolitical Fragmentation Global Fragmentation Healthcare Healthy Longevity high yield dividend stocks High-Yield Credit Higher-for-Longer Humanoid Robots Industrials Inflation Stickiness Japan K-Economy Low Correlation Asset MANGOS Market Breadth Multipolar World NACHO New Energy Supply Chain New Quality Productive Forces Nuclear Renaissance Offshore Revenue Growth Oil Price Volatility Oil Shock Politics of Energy Power Grid Growth Powering AI Premium Manufacturing Premium State-owned Enterprises Private Equity Diversification Private Market Liquidity RMB Asset Safe Haven Robotics s&p 500 S&P 7000 Semiconductor Equipment Semiconductors Share Buybacks Smart Consumer Electronics Societal Shifts Soft Landing Software & Internet Applications Sticky Inflation Strong Corporate Earnings Structural Opportunities Structural Transformation Supply Chain Resilience TACO Tech Diffusion Tech Localization Technology-Driven Export Growth US Equities USD Bullishness Value Play Vertical AI

Leave a Reply Cancel reply

©2026 INVESTORS HEALTH WordPress Video Theme by WPEnjoy